Tag Archives: king pharmaceuticals
Perry hedge fund settles with SEC over Mylan stake
Reuters – Hedge fund firm Perry Corp will pay $150,000 to settle accusations that it failed to report a substantial stake in Mylan Inc, purchased to support a proposed 2004 takeover of King Pharmaceuticals, the U.S. Securities and Exchange Commission […]
